Anti-inflammatory,free radical scavenging and alpha-glucosidase inhibitory activities of Hamelia patens and its chemical constituents

Context Hamelia patens Jacq. (Rubiaceae) is traditionally used to treat wounds, inflammation and diabetes. However, there is still a lack of scientific evidence to support these applications.

Objective The objective of this study is to evaluate the anti-inflammatory, antioxidant and antidiabetic activities of Hamelia patens, and identify its bioactive compounds.

Materials and methods Four extracts were obtained by maceration and liquid–liquid extraction: HEX, DCM–EtOAc, MeOH–EtOAc and MeOH–Aq. The anti-inflammatory effect was evaluated orally on rat paw carrageenan-induced oedema over 6?h (50, 200 and 500?mg/kg), and topically in mouse ear oedema induced by 12-tetradecanoylphorbol-13-acetate (TPA) after 4?h (0.5 and 1?mg/ear). We also evaluated myeloperoxidase levels in ear tissue, 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging ability, and in vitro α-glucosidase inhibition. The chemical compounds were separated by column chromatography and identified by spectroscopic analysis.

Results We found that the oral administration of the HEX extract at 500 and 200?mg/kg significantly decreased the carrageenan-induced inflammation after 1 and 3?h, respectively. The MeOH–EtOAc extract significantly inhibited myeloperoxidase activity (83.5%), followed by the DCM–EtOAc extract (76%), β-sitosterol/stigmasterol (72.7%) and the HEX extract (55%), which significantly decreased oedema induced by TPA at both doses, giving a similar effect to indomethacin. We also found that the MeOH–EtOAc, MeOH–Aq and DCM–EtOAc extracts showed good DPPH scavenging activity (IC₅₀ values of 18.6, 93.9 and 158.2?μg/mL, respectively). The HEX extract showed the lowest α-glucosidase inhibition (an IC₅₀ value of 26.07?μg/mL), followed by the MeOH–EtOAc extract (an IC₅₀ value of 30.18?μg/mL), β-sitosterol/stigmasterol (IC₅₀ 34.6?μg/mL) and compound A ((6E,10E,14E,18E)-2,6,10,14,18,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene, an IC₅₀ value of 114.6?μg/mL), which were isolated for the first time from Hamelia patens.

Discussion and conclusion Hamelia patens possesses anti-inflammatory, antioxidant and α-glucosidase inhibitory activities, which support its traditional use. These effects can be attributed to the identified compounds.